Ivachtchenko AV - Search Results

1

Non-dopamine receptor ligands for the treatment of Parkinson's disease. Insight into the related chemical/property space.

Ivanenkov YA, Veselov MS, Chufarova NV, Majouga AG, Kudryavceva AA, Ivachtchenko AV. Ivanenkov YA, et al. Among authors: ivachtchenko av. Mol Divers. 2016 Feb;20(1):345-65. doi: 10.1007/s11030-015-9598-y. Epub 2015 May 9. Mol Divers. 2016. PMID: 25956815 Review.

2

5-hydroxytryptamine subtype 6 receptor modulators: a patent survey.

Ivachtchenko AV, Ivanenkov YA, Tkachenko SE. Ivachtchenko AV, et al. Expert Opin Ther Pat. 2010 Sep;20(9):1171-96. doi: 10.1517/13543776.2010.494661. Expert Opin Ther Pat. 2010. PMID: 20716023 Review.

3

5HT(6) receptor antagonists: a patent update. Part 1. Sulfonyl derivatives.

Ivachtchenko AV, Ivanenkov YA. Ivachtchenko AV, et al. Expert Opin Ther Pat. 2012 Aug;22(8):917-64. doi: 10.1517/13543776.2012.709236. Expert Opin Ther Pat. 2012. PMID: 22816965 Review.

4

A Comprehensive Insight into the Chemical Space and ADME Features of Small Molecule NS5A Inhibitors.

Ivanenkov YA, Veselov MS, Shakhbazyan AG, Aladinskiy VA, Aladinskaya AV, Yartseva SM, Majouga AG, Vantskul AS, Leonov SV, Ivachtchenko AV, Koteliansky VE. Ivanenkov YA, et al. Among authors: ivachtchenko av. Curr Top Med Chem. 2016;16(12):1372-82. doi: 10.2174/1568026616666151120113040. Curr Top Med Chem. 2016. PMID: 26585933 Review.

5

Regulators of chemokine receptor activity as promising anticancer therapeutics.

Balakin KV, Ivanenkov YA, Tkachenko SE, Kiselyov AS, Ivachtchenko AV. Balakin KV, et al. Among authors: ivachtchenko av. Curr Cancer Drug Targets. 2008 Jun;8(4):299-340. doi: 10.2174/156800908784533490. Curr Cancer Drug Targets. 2008. PMID: 18537553 Review.

6

5-HT(6) receptor modulators: a patent update. Part 2. Diversity in heterocyclic scaffolds.

Ivachtchenko AV, Ivanenkov YA, Skorenko AV. Ivachtchenko AV, et al. Expert Opin Ther Pat. 2012 Oct;22(10):1123-68. doi: 10.1517/13543776.2012.722205. Epub 2012 Sep 7. Expert Opin Ther Pat. 2012. PMID: 22957857 Review.

7

Design, synthesis and biological evaluation of novel 5-oxo-2-thioxoimidazolidine derivatives as potent androgen receptor antagonists.

Ivachtchenko AV, Ivanenkov YA, Mitkin OD, Vorobiev AA, Kuznetsova IV, Shevkun NA, Koryakova AG, Karapetian RN, Trifelenkov AS, Kravchenko DV, Veselov MS, Chufarova NV. Ivachtchenko AV, et al. Eur J Med Chem. 2015 Jun 24;99:51-66. doi: 10.1016/j.ejmech.2015.05.039. Epub 2015 Jun 2. Eur J Med Chem. 2015. PMID: 26046313

8

In Silico Approaches to the Design of NS5A Inhibitors.

Ivanenkov YA, Veselov MS, Aladinskiy VA, Shakhbazyan AG, Yartseva SM, Majouga AG, Aladinskaya AV, Vantskul AS, Leonov SV, Ivachtchenko AV, Koteliansky VE. Ivanenkov YA, et al. Among authors: ivachtchenko av. Curr Top Med Chem. 2016;16(12):1383-91. doi: 10.2174/1568026616666151120113705. Curr Top Med Chem. 2016. PMID: 26585932 Review.

9

AVN-211, Novel and Highly Selective 5-HT6 Receptor Small Molecule Antagonist, for the Treatment of Alzheimer's Disease.

Ivachtchenko AV, Lavrovsky Y, Ivanenkov YA. Ivachtchenko AV, et al. Mol Pharm. 2016 Mar 7;13(3):945-63. doi: 10.1021/acs.molpharmaceut.5b00830. Epub 2016 Feb 26. Mol Pharm. 2016. PMID: 26886442

10

Small-molecule inhibitors of hepatitis C virus (HCV) non-structural protein 5A (NS5A): a patent review (2010-2015).

Ivanenkov YA, Aladinskiy VA, Bushkov NA, Ayginin AA, Majouga AG, Ivachtchenko AV. Ivanenkov YA, et al. Among authors: ivachtchenko av. Expert Opin Ther Pat. 2017 Apr;27(4):401-414. doi: 10.1080/13543776.2017.1272573. Epub 2017 Jan 10. Expert Opin Ther Pat. 2017. PMID: 27967269 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters